Evidence map›Paper›PMID 29968113›Full record

ArticleInternational journal of computer assisted radiology and surgery2019

Clinical use of an opto-nuclear probe for hybrid sentinel node biopsy guidance: first results.

Sergi Vidal-Sicart, Antonio Seva, Francisco Campos, Núria Sánchez, Immaculada Alonso, Jaume Pahisa, Xavier Caparrós, Andrés Perissinotti, Pilar Paredes, Fijs W van Leeuwen

Abstract read
PubMed Publisher
In one paragraph

Article in International journal of computer assisted radiology and surgery, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Molecular image-guided surgery in gynaecological cancer: where do we stand?European journal of nuclear medicine and molecular imaging · 2024
    Review
  4. The current status and future prospects for molecular imaging-guided precision surgery.Cancer imaging : the official publication of the International Cancer Imaging Society · 2022
    Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Sergi Vidal-SicartNuclear Medicine Department, CDI, Hospital Clinic Barcelona, Villarroel 170, 08036, Barcelona, Spain. svidal@clinic.cat.ORCID http://orcid.org/0000-0002-6303-3606
Antonio SevaNuclear Medicine Department, CDI, Hospital Clinic Barcelona, Villarroel 170, 08036, Barcelona, Spain.
Francisco CamposNuclear Medicine Department, CDI, Hospital Clinic Barcelona, Villarroel 170, 08036, Barcelona, Spain.
Núria SánchezNuclear Medicine Department, CDI, Hospital Clinic Barcelona, Villarroel 170, 08036, Barcelona, Spain.
Immaculada AlonsoGynaecology Department, ICGON, Hospital Clinic Barcelona, Barcelona, Spain.
Jaume PahisaGynaecology Department, ICGON, Hospital Clinic Barcelona, Barcelona, Spain.
Xavier CaparrósGynaecology Department, ICGON, Hospital Clinic Barcelona, Barcelona, Spain.
Andrés PerissinottiNuclear Medicine Department, CDI, Hospital Clinic Barcelona, Villarroel 170, 08036, Barcelona, Spain.
Pilar ParedesNuclear Medicine Department, CDI, Hospital Clinic Barcelona, Villarroel 170, 08036, Barcelona, Spain.
Fijs W van LeeuwenInterventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Hospital, Leiden, The Netherlands.
Hospital Clínic de Barcelona · ESLeiden University Medical Center · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionGuidelines advocate the use of combined detection techniques to achieve optimal results for sentinel node (SN) biopsy. The fluorescent and radioactive (dual-) tracer ICG-

methodsThirty-three patients scheduled for SN biopsy with the dual-tracer were retrospectively analyzed. Pre-operative lymphoscintigraphy was performed in all patients; in 18 patients (55%), a SPECT/CT scan was also performed. Radioactive and fluorescent signatures in the SNs were assessed in vivo and ex vivo using the opto-nuclear probe.

resultsOne or more SNs were identified in all patients (identification rate 100%). Planar lymphoscintigraphic images revealed 95 hot spots that were considered as SNs. This number increased to 103 SNs when SPECT/CT was used. During surgery, 106 SNs were excised. In vivo, the fluorescence mode of the opto-nuclear probe was able to locate 79 SNs (74.5%). When the gamma-ray detection option of the same probe was used, this number increased to 99 SNs (93.3%). Ex vivo analysis revealed fluorescence in 93.3% of the excised nodes and radioactivity in 95.2%.

conclusionsThis study underlines the feasibility of using the dual-tracer/opto-nuclear probe combination for SN resections. The use of the opto-nuclear technology has been extended to laparoscopic surgery. This study also underlines the fluorescence tracing can complement traditional radio-tracing approaches.

Indexed as

AdultAgedColoring AgentsFemaleFluorescenceGamma RaysHumansIndocyanine GreenLaparoscopyLymph NodesLymphoscintigraphyMaleMiddle AgedRetrospective StudiesSentinel Lymph Node BiopsySurgery, Computer-AssistedColoring AgentsIndocyanine GreenTechnetium Tc 99m Aggregated AlbuminBi-modalDual-tracerFluorescenceHybridImage-guided surgerySentinel nodeSPECT

Identifiers

PMID29968113
OpenAlexW2809979941

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.